STRATA Skin Sciences Inc
SSKN1.270USD
+0.050+4.10%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
6.69MMarket Cap
LossP/E TTM
More Details of STRATA Skin Sciences Inc Company
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
STRATA Skin Sciences Inc Info
Ticker SymbolSSKN
Company nameStrata Skin Sciences Inc
IPO dateOct 28, 2005
CEORafaeli (Dolev)
Number of employees106
Security typeOrdinary Share
Fiscal year-endOct 28
Address5 Walnut Grove Drive, Suite 140
CityHORSHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19044
Phone12156193200
Websitehttps://www.strataskinsciences.com/
Ticker SymbolSSKN
IPO dateOct 28, 2005
CEORafaeli (Dolev)
Company Executives of STRATA Skin Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%
Mr. Shmuel (Samuel) Rubinstein
Mr. Shmuel (Samuel) Rubinstein
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Christina L. Allgeier, CPA
Ms. Christina L. Allgeier, CPA
Independent Director
Independent Director
--
--
Mr. John Gillings
Mr. John Gillings
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Shmuel Gov
Mr. Shmuel Gov
Chief Operating Officer
Chief Operating Officer
--
-100.00%
Dr. Irit Yaniv
Dr. Irit Yaniv
Independent Director
Independent Director
--
--
Dr. Uri Geiger
Dr. Uri Geiger
Chairman of the Board
Chairman of the Board
--
--
Dr. Dolev Rafaeli
Dr. Dolev Rafaeli
President, Chief Executive Officer, Vice Chairman of the Board
President, Chief Executive Officer, Vice Chairman of the Board
--
-100.00%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States (Country)
5.06M
66.03%
China
1.66M
21.65%
Foreign
456.00K
5.95%
Middle East
307.00K
4.01%
Other foreign
181.00K
2.36%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
Other
51.60%
Shareholders
Shareholders
Proportion
Accelmed Growth Partners Management Ltd
24.49%
22NW, LP
9.12%
Nantahala Capital Management, LLC
6.86%
Lincoln Alternative Strategies LLC
6.21%
Renaissance Technologies LLC
1.72%
Other
51.60%
Shareholder Types
Shareholders
Proportion
Private Equity
24.49%
Investment Advisor/Hedge Fund
9.60%
Hedge Fund
8.62%
Corporation
6.21%
Investment Advisor
1.36%
Individual Investor
0.18%
Other
49.54%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
40
2.60M
49.33%
-171.52K
2025Q2
42
2.84M
68.01%
+22.22K
2025Q1
49
2.92M
70.24%
+3.78K
2024Q4
50
2.78M
66.72%
+102.20K
2024Q3
53
2.77M
66.42%
+227.70K
2024Q2
54
2.39M
67.77%
-279.08K
2024Q1
55
2.43M
68.82%
-232.89K
2023Q4
54
2.50M
71.18%
-175.24K
2023Q3
53
2.57M
73.29%
-212.86K
2023Q2
52
2.46M
70.54%
-108.10K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Accelmed Growth Partners Management Ltd
1.44M
27.37%
--
--
Sep 04, 2025
22NW, LP
537.00K
10.19%
--
--
Jun 30, 2025
Nantahala Capital Management, LLC
403.92K
7.67%
--
--
Jun 30, 2025
Lincoln Alternative Strategies LLC
365.85K
6.94%
+365.85K
--
Sep 03, 2025
Renaissance Technologies LLC
98.03K
1.86%
-3.80K
-3.73%
Jun 30, 2025
The Vanguard Group, Inc.
84.63K
1.61%
--
--
Jun 30, 2025
Azzad Asset Management, Inc.
12.00K
0.23%
+1.00K
+9.09%
Jun 30, 2025
Geode Capital Management, L.L.C.
18.19K
0.35%
-76.00
-0.42%
Jun 30, 2025
MGO One Seven LLC
17.14K
0.33%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Date
Type
Ratio
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
Apr 26, 2024
Merger
10→1
FAQs
Who are the top five shareholders of STRATA Skin Sciences Inc?
The top five shareholders of STRATA Skin Sciences Inc are:
Accelmed Growth Partners Management Ltd holds 1.44M shares, accounting for 27.37% of the total shares.
22NW, LP holds 537.00K shares, accounting for 10.19% of the total shares.
Nantahala Capital Management, LLC holds 403.92K shares, accounting for 7.67% of the total shares.
Lincoln Alternative Strategies LLC holds 365.85K shares, accounting for 6.94% of the total shares.
Renaissance Technologies LLC holds 98.03K shares, accounting for 1.86% of the total shares.
Accelmed Growth Partners Management Ltd holds 1.44M shares, accounting for 27.37% of the total shares.
22NW, LP holds 537.00K shares, accounting for 10.19% of the total shares.
Nantahala Capital Management, LLC holds 403.92K shares, accounting for 7.67% of the total shares.
Lincoln Alternative Strategies LLC holds 365.85K shares, accounting for 6.94% of the total shares.
Renaissance Technologies LLC holds 98.03K shares, accounting for 1.86% of the total shares.
What are the top three shareholder types of STRATA Skin Sciences Inc?
The top three shareholder types of STRATA Skin Sciences Inc are:
Accelmed Growth Partners Management Ltd
22NW, LP
Nantahala Capital Management, LLC
Accelmed Growth Partners Management Ltd
22NW, LP
Nantahala Capital Management, LLC
How many institutions hold shares of STRATA Skin Sciences Inc (SSKN)?
As of 2025Q3, 40 institutions hold shares of STRATA Skin Sciences Inc, with a combined market value of approximately 2.60M, accounting for 49.33% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -18.69%.
What is the biggest source of revenue for STRATA Skin Sciences Inc?
In FY2025Q2, the -- business generated the highest revenue for STRATA Skin Sciences Inc, amounting to -- and accounting for --% of total revenue.
